Centre for Clinical Research in Emergency Medicine (CCREM)


http://www.ccrem.org.au
Emergency Department

The Centre for Clinical Research in Emergency Medicine (CCREM) is a new Centre within the Western Australian Institute for Medical Research (WAIMR) focused on research activities within the spectrum of Emergency Medicine.

Our research involves collaboration between clinical academics working in the Emergency Department (ED), research nurses collecting samples from patients presenting to the ED with acute illnesses and basic scientists analysing samples in the laboratory using immunological and molecular biological techniques. Current projects include:-

· Venom Allergy Studies – identification of specific allergens within Australian ant species that trigger severe, life-threatening allergy (anaphylaxis), a randomised controlled trial of different methods of Venom Immunotherapy (VIT) to prevent anaphylaxis, and a variety of laboratory studies to assess changes in venom-specific immunoglobulin and cytokine responses during the time course of immunotherapy and how these correlate with clinical endpoints.

· Emergency Department Anaphylaxis (EDA), Australian Snakebite Project (ASP) and the Redback Antivenom Evaluation (RAVE) Studies, as a member of the Snakebite, Toxicology, Anaphylaxis, Redback (STAR) collaboration (www.star.ferntree.com):

  • The EDA study aims to define the clinical spectrum of anaphylaxis, biochemical mediators and responses to treatment. This involves analysing samples collected from patients presenting to the ED with acute anaphylaxis for potential markers of mast cell degranulation and immune system activation (cytokines, leukotrienes etc). This work is now being expanded to include identification of potential genetic risk factors for severe anaphylaxis.
  • The ASP and RAVE studies investigate the clinical nature of envenomings and responses to the specific antivenoms used to treat them. Within the STAR collaboration, CCREM has a particular interest in the nature of anaphylaxis and other immunological reactions to antivenoms and venoms.

· Chest Pain Studies - development of a new method to assess chest pain presenting to the ED using a multi-marker approach to exclude cardiac conditions.

· Illnesses affecting the Elderly - including long term follow up of elderly patients with diastolic heart failure and developing methods to improve the clinical differentiation between acute systolic and diastolic heart failure in elderly patients.

· Sepsis/Shock Studies - examine the early human immune responses to sepsis and shock in adults and elderly patients presenting to the ED.

WAIMRAmphetamines turn you into something you can't see for yourself

20% of regular amphetamine users tested under the age of 30 have been found to have an 'abnormality of the brain'. At that age, it should be less than 1%.

More »

Pauline van EedenDr Pauline van Eeden Awarded Grant

We would like to congratulate Dr Pauline van Eeden on being awarded a $30,000 UWA Research Development Award to study "Differential Gene Regulation during Elderly Sepsis: Correlation with poor Clinical Outcomes". The research hopes to improve initial diagnosis of sepsis in the elderly and provide targets for future treatment improvements. Well done Pauline!

CatalystAnt Venom on ABC Catalyst

For those with an allergy to ant stings, just one jab from a Jack Jumper ant can cause extreme illness and in the worst of cases death. But, a team of researchers in Tasmania have come up with an ingenious treatment that reduces sensitivity to the insects allergens.

Video and Transcript »
Catalyst Blog »

AntNative Ants are Deadly Threat

Bulldog ants commonly found on the Darling Scarp are in a group of four potential killer native ant species identified in a new study.

Article in The West »
Scientific Paper »